Search Results - Holden T. Maeker

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF

    Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF by Shirley Y. Jiang, Shu Cao, Kristine Martinez, Reyna Sharma, Olivia Raeber, Andrea Fernandes, Dinara Bogetic, Abhinav Kaushik, Sheena Gupta, Monali Manohar, Holden T. Maeker, Andrew R. Chin, Andrew J. Long, Catherine Feight, Margaret Woch, Kari C. Nadeau, R. Sharon Chinthrajah, Sayantani B. Sindher

    Published 2025-07-01

    IntroductionShrimp is a common but understudied food allergen with relatively high rates of emergency department visits. Here we report the shrimp OIT outcomes in the MOTIF (NCT03504774) clinical trial and discuss some of the challenges with performing this study.MethodsIn this phase 2 clinical tria...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: